Advances in informatics technology are inspiring a new generation of innovative products that streamline and enhance the efficiency and productivity of the Design-Make-Test-Analyse (DMTA) drug discovery process. Scientists are busy creating and analyzing 1000s to millions of different entities (like small molecules, cell lines, or antibodies), throughout their drug discovery process and running 100s to 1000s of different assays over all of these entities. These assays or protocols need to be devised, annotated, and ultimately reduced to a definition for the kinds of data being captured for later analysis. Once that's done, millions, even billions, of rows of data from all over the place (like CROs, partners, academic screening centers, etc) are being acquired from across the globe. All of this data needs to be looked at by a collection of scientists who need to be able to access this data in many different ways. Finally, all of this data gets pulled together and summarized in all sorts of documents and reports containing structured and unstructured data. For decades, scientists have used various tools to manage the people and the data being generated. From paper notebooks, to flat files, various desktop tools, complicated mainframe database applications, and others, working with all these tools has resulted in an array of unique challenges. With CDD Vault, there's a new and better way of managing this Design-Make-Test-Analyse (DMTA) process. CDD Vault combines the capabilities previous tools into 1 easy to use, cloud-based platform. With 0 foot print and a full deployment within 2 hours, CDD Vault is an intuitive, highly secure platform that anchors your scientific informatics ecosystem.

Best practices for small to mid-size companies to advance drug discovery programs

ACS Fall 2021

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.